Replimune Group Depreciation & Amortization Growth & History (REPL)
Replimune Group's depreciation and amortization was $3.3M for fiscal 2026.
View full Replimune Group company overviewReplimune Group annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $3.3M | −$170,000 | −4.85% |
| 2025 | 2025-03-31 | $3.5M | $847,000 | +31.90% |
| 2024 | 2024-03-31 | $2.7M | $208,000 | +8.50% |
| 2023 | 2023-03-31 | $2.4M | $300,000 | +13.97% |
| 2022 | 2022-03-31 | $2.1M | $436,000 | +25.48% |
| 2021 | 2021-03-31 | $1.7M | $1.2M | +221.01% |
| 2020 | 2020-03-31 | $533,000 | $385,000 | +260.14% |
| 2019 | 2019-03-31 | $148,000 | $39,000 | +35.78% |
| 2018 | 2018-03-31 | $109,000 | −$13,000 | −10.66% |
| 2017 | 2017-03-31 | $122,000 | — | — |
Replimune Group quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $937,000 | $64,000 | +7.33% |
| Q4 2026 | 2026-03-31 | $769,000 | −$79,000 | −9.32% |
| Q3 2026 | 2025-12-31 | $800,000 | −$200,000 | −20.00% |
| Q2 2026 | 2025-09-30 | $800,000 | −$100,000 | −11.11% |
| Q1 2026 | 2025-06-30 | $873,000 | $137,000 | +18.61% |
| Q4 2025 | 2025-03-31 | $848,000 | — | — |
| Q3 2025 | 2024-12-31 | $1.0M | $300,000 | +42.86% |
| Q2 2025 | 2024-09-30 | $900,000 | $200,000 | +28.57% |
| Q1 2025 | 2024-06-30 | $736,000 | $115,000 | +18.52% |
| Q3 2024 | 2023-12-31 | $700,000 | $18,000 | +2.64% |
| Q2 2024 | 2023-09-30 | $700,000 | $83,000 | +13.45% |
| Q1 2024 | 2023-06-30 | $621,000 | $1,000 | +0.16% |
| Q3 2023 | 2022-12-31 | $682,000 | $134,000 | +24.45% |
| Q2 2023 | 2022-09-30 | $617,000 | $85,000 | +15.98% |
| Q1 2023 | 2022-06-30 | $620,000 | $102,000 | +19.69% |
| Q3 2022 | 2021-12-31 | $548,000 | $146,000 | +36.32% |
| Q2 2022 | 2021-09-30 | $532,000 | $107,000 | +25.18% |
| Q1 2022 | 2021-06-30 | $518,000 | $127,000 | +32.48% |
| Q3 2021 | 2020-12-31 | $402,000 | $295,000 | +275.70% |
| Q2 2021 | 2020-09-30 | $425,000 | $383,000 | +911.90% |
| Q1 2021 | 2020-06-30 | $391,000 | $349,000 | +830.95% |
| Q3 2020 | 2019-12-31 | $107,000 | $70,000 | +189.19% |
| Q2 2020 | 2019-09-30 | $42,000 | $6,000 | +16.67% |
| Q1 2020 | 2019-06-30 | $42,000 | $9,000 | +27.27% |
| Q3 2019 | 2018-12-31 | $37,000 | $6,000 | +19.35% |
| Q2 2019 | 2018-09-30 | $36,000 | $9,000 | +33.33% |
| Q1 2019 | 2018-06-30 | $33,000 | $10,000 | +43.48% |
| Q3 2018 | 2017-12-31 | $31,000 | — | — |
| Q2 2018 | 2017-09-30 | $27,000 | — | — |
| Q1 2018 | 2017-06-30 | $23,000 | — | — |
Replimune Group depreciation and amortization trends
Over the last five fiscal years, Replimune Group's depreciation and amortization increased from $1.7M to $3.3M, a change of $1.6M. The latest reported quarter, Q1 2027, shows $937,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Replimune Group source filings ↗